Buy Token
×
Site Menu
Everything
cryptocurrency
Buy Token
Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic
4 months ago
232
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic and Wegovy.
Read Entire Article
Homepage
category-label-
Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic
Related
Why it may be better if your children don’t have to wait to ...
15 minutes ago
0
The year-end tax moves that can lower your tax bill and make...
25 minutes ago
0
There are much better ways to help your favorite charities t...
34 minutes ago
0
Trending
Popular
Warning: WhatsApp worm targets Brazilian crypto wallets, ban...
4 weeks ago
127
Why the once-invincible Nvidia can’t save the AI trade
3 weeks ago
122
Nasdaq ISE Files to Lift BlackRock IBIT Option Limits Into T...
3 weeks ago
118
Strategy and Bitcoin supporters call for 'boycott' of JP Mor...
3 weeks ago
114
XRP price at risk of a 25% drop to $1.55: Here is why
4 weeks ago
113
Bitcoin whale activity on track for its biggest week this ye...
4 weeks ago
112
MSCI index likely to kick out crypto treasuries, exec warns
4 weeks ago
111
Why investors should hope this Cyber Monday is a down day fo...
2 weeks ago
104
Sovereign Bitcoin adoption would be the ultimate upside cata...
3 weeks ago
98
Palo Alto Networks’ earnings fail to wow Wall Street — even ...
4 weeks ago
98